About the WHO Global Malaria Programme
The WHO Global Malaria Programme (GMP) is responsible for the coordination of WHO's global efforts to control and eliminate malaria. The Programme sets evidence-based norms, standards, policies and guidelines to support malaria-affected countries around the world. As one of its key mandates, the Programme also keeps independent score of global progress in the fight against malaria. Its flagship annual publication, the World Malaria Report, contains the latest available data on the impact of malaria interventions around the world.
GMP’s activities are focused on providing an integrated solution to the various epidemiological and operational challenges that affect different parts of the world. The Programme’s unique position – uniting high levels of expertise and WHO's field presence in all regions and endemic countries – ensures harmonized policy advice on all technical and programmatic challenges at the national, regional and global level. GMP’s policy guidance on prevention, case management, surveillance, monitoring and evaluation, and malaria elimination provides a benchmark for national malaria programmes and multilateral funding agencies.
In 2011, WHO redesigned its policy-setting process on malaria to make it more responsive to the rapidly evolving epidemiological and development context. A Malaria Policy Advisory Committee (MPAC) was established to provide independent advice to WHO with regard to policy recommendations for the control and elimination of malaria. Under the umbrella of the MPAC, WHO also convenes expert groups to review evidence and make recommendations.
Key partners and funders
GMP works closely with all major partners in the global malaria community: with endemic country governments and regulatory authorities, UN agencies, inter-governmental organizations, private-public partnerships and campaign groups. The Department also participates in all major inter-agency taskforces, and in multi-partner and multi-sectoral initiatives on malaria. Its experts lead several technical working groups within the Roll Back Malaria partnership, of which WHO is a founding partner.
The work of the Global Malaria Programme is currently supported (in alphabetical order) by the Bill & Melinda Gates Foundation, the Canadian International Development Agency, the Government of Australia, the Government of Norway, the Government of Japan, the Government of the Russian Federation, the Government of the United Kingdom, and the United States Agency for International Development. Funding is also received through the Medicines for Malaria Venture, the Foundation for Innovative New Diagnostics, the Global Fund to Fight AIDS, Tuberculosis and Malaria and through the core WHO budget.
GMP’s key partners (in alphabetical order) include the African Leaders Malaria Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Foundation for Innovative New Diagnostics, Imperial College London, the Innovative Vector Control Consortium, the Institute for Health Metrics and Evaluation, ISGlobal, the Johns Hopkins Bloomberg School of Public Health, the Medicines for Malaria Venture, the Office of the UN Special Envoy for Malaria, PATH, the Swiss Tropical and Public Health Institute, UNICEF, UNITAID, the University of Oxford, the United States President's Malaria Initiative, the United States Centers for Disease Control, and many others.
The Global Malaria Programme is led by Dr Pedro L. Alonso. The department is housed in WHO's HIV/AIDS, Tuberculosis and Malaria cluster, led by Assistant Director-General Dr Winnie Mpanju-Shumbusho. The work is managed through four units - Diagnostics, Treatment and Vaccines, led by Dr Andrea Bosman; Drug Resistance and Containment, led by Dr Pascal Ringwald; Strategy, Economics and Elimination, led by Dr Richard Cibulskis; and Vector Control, led by Dr Abraham Mnzava. The department’s Programme Manager is Erin Shutes; administration is led by Simone Colairo.
The department's publications are available electronically on this website and hardcopies are distributed to Ministries of Health in endemic countries and to key partners. Some publications are also available for purchase through the WHO Online Bookshop. The department's flagship publication, the World Malaria Report, is published annually in December.